ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 D...
FDA Recall #D-1071-2023 — Class II — July 17, 2023
Product Description
ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1
Reason for Recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recalling Firm
Central Admixture Pharmacy Services Inc — San Diego, CA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
2,994 syringes
Distribution
Nationwide in the USA
Code Information
Lot: 17-274122, 17-274147, 17-274155, 17-274158, 17-274162, Exp. 9/13/2023
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated